Related Experiment Video
Updated: May 16, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Nicotine vapor inhalation escalates nicotine self-administration
Nicholas W Gilpin1, Annie M Whitaker, Brittni Baynes
1Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Chronic intermittent nicotine vapor inhalation in rats led to escalated nicotine self-administration and withdrawal symptoms, modeling human nicotine dependence. This research advances pre-clinical models for nicotine addiction.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Human cigarette smoking escalates over time.
- Pre-clinical models struggle to replicate escalated nicotine self-administration in rats.
Purpose of the Study:
- To establish a rat model of escalated nicotine self-administration using chronic intermittent nicotine vapor inhalation.
- To assess the development of nicotine dependence, including somatic and motivational signs.
Main Methods:
- Rats underwent chronic intermittent nicotine vapor exposure (12 hours/day).
- Nicotine self-administration was assessed via operant responding during withdrawal periods.
- Somatic signs of nicotine withdrawal were measured, both spontaneously and precipitated by mecamylamine.
Main Results:
- Nicotine vapor-exposed rats escalated nicotine self-administration significantly compared to baseline and controls.
- Intermittent testing revealed transient increases in responding, followed by a nicotine deprivation effect.
- Rats exhibited robust mecamylamine-precipitated somatic signs of withdrawal 8 hours post-vapor exposure.
- Nicotine concentrations mimicked those experienced by human smokers.
Conclusions:
- Chronic intermittent nicotine vapor inhalation effectively induces escalated nicotine self-administration, a key motivational sign of dependence.
- This model also produces somatic signs of nicotine withdrawal, further validating its utility.
- The findings provide a valuable pre-clinical tool for studying nicotine addiction mechanisms and potential treatments.
More Related Videos
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...

